cCAM Biotherapeutics
is focused on the discovery and development of novel immunotherapies to treat cancer... Read morecCAM Biotherapeutics
is focused on the discovery and development of novel immunotherapies to treat cancer... Read more
News
Mar 09, 2017
BioPortfolio
cCAM Biotherapeutics: Lawsuit claims Arkin misled eCam shareholders
Jul 30, 2015
PHARAMCEUTICAL TECHNOLOGY
cCAM Biotherapeutics:
Merck to acquire Israel's cCAM Biotherapeutics for $605m
Jul 29, 2015
BIOPHARMA-REPORTER
cCAM Biotherapeutics: Merck & Co. 'continues to augment' biologics pipeline with $605m cCAM deal
Jul 28, 2015
BUSINESS WIRE
Press Release: cCAM Biotherapeutics : Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
Jul 28, 2015
4-TRADERS
cCAM Biotherapeutics: Merck : Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
Apr 20, 2015
BIOSPACE
cCAM Biotherapeutics: <b>cCam Biotherapeutics</b> Announces Initiation Of Phase 1 Trial Of CM-24, A Novel Immune Checkpoint Inhibitor For Cancer Immunotherapy
Apr 20, 2015
BUSINESS WIRE
Press Release: cCAM Biotherapeutics : cCAM Biotherapeutics Announces Initiation of Phase 1 Trial of CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy
Jan 07, 2015
NOCAMELS
cCAM Biotherapeutics: cCAM Biotherapeutics Receives Phase I FDA Approval
Jan 06, 2015
BUSINESS WIRE
Press Release: cCAM Biotherapeutics : cCAM Biotherapeutics Receives FDA Approval to Initiate Phase 1 Trial for CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy
cCAM Biotherapeutics Competitors
1
2
3
4
5
6
7
8
9
10